Previous Section
Review Articles
61. Novel pharmacological targets for the treatment of Parkinson's disease.
- Author
- Schapira AH; Bezard E; Brotchie J; Calon F; Collingridge GL; Ferger B; Hengerer B; Hirsch E; Jenner P; Le Novere N; Obeso JA; Schwarzschild MA; Spampinato U; Davidai G;
- Institution
- University Department of Clinical Neurosciences, Royal Free and University College Medical School, University College London, Rowland Hill Street, London NW3 2PF, UK. a.schapira@medsch.ucl.ac.uk
- Journal
- Nat Rev Drug Discov. 2006 Oct;5(10):845-54.
- Abstract URL
- Click here to view abstract
62. Rotigotine for the treatment of Parkinson's disease.
- Author
- Morgan JC; Sethi KD;
- Institution
- Movement Disorders Program, Department of Neurology, Medical College of Georgia,1429 Harper Street, HF-1121 Augusta, GA 30912, USA. jmorgan@mcg.edu
- Journal
- Expert Rev Neurother. 2006 Sep;6(9):1275-82.
- Abstract URL
- Click here to view abstract
63. Cognitive, affective, and psychiatric features of Parkinson's disease.
- Author
- Barbas NR;
- Institution
- Department of Neurology, University of Michigan, 1920 Taubman Center 0316, 1500 Medical Center Drive, Ann Arbor, MI 48109-0316, USA. nbarbas@med.umich.edu
- Journal
- Clin Geriatr Med. 2006 Nov;22(4):773-96, v-vi.
- Abstract URL
- Click here to view abstract
64. Medical management of advanced Parkinson's disease.
- Author
- Goudreau JL;
- Institution
- Department of Neurology and Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48842, USA. john.goudreau@ht.msu.edu
- Journal
- Clin Geriatr Med. 2006 Nov;22(4):753-72, v.
- Abstract URL
- Click here to view abstract
65. Parkinson's disease: background, diagnosis, and initial management.
- Author
- Albin RL;
- Institution
- Geriatrics Research, Education, and Clinical Center, Veterans Administration Medical Center, Ann Arbor, MI 48109-0585, USA. ralbin@umich.edu
- Journal
- Clin Geriatr Med. 2006 Nov;22(4):735-51, v.
- Abstract URL
- Click here to view abstract
66. Drug Insight: new drugs in development for Parkinson's disease.
- Author
- Colosimo C; Fabbrini G; Berardelli A;
- Institution
- University Department of Neurosciences University of Rome, La Sapienza, Italy. carlo.colosimo@uniroma1.it
- Journal
- Nat Clin Pract Neurol. 2006 Nov;2(11):600-10.
- Abstract URL
- Click here to view abstract
67. Tolcapone in the management of Parkinson's disease.
- Author
- Leegwater-Kim J; Waters C;
- Institution
- Columbia University Medical Center, Department of Neurology, Division of Movement Disorders, 710 W. 168th Street, New York, NY 10032, USA.
- Journal
- Expert Opin Pharmacother. 2006 Nov;7(16):2263-70.
- Abstract URL
- Click here to view abstract
68. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.
- Author
- Nyholm D;
- Institution
- Department of Neuroscience, Neurology, Uppsala University Hospital, SE-75185, Uppsala, Sweden. dag.nyholm@neurologi.uu.se
- Journal
- Expert Rev Neurother. 2006 Oct;6(10):1403-11.
- Abstract URL
- Click here to view abstract
69. Parkinson's disease: diagnosis and treatment.
- Author
- Rao SS; Hofmann LA; Shakil A;
- Institution
- University of Texas Southwestern Medical School at Dallas Family Medicine Residency Program, Dallas, Texas 75390, USA. shobha.rao@utsouthwestern.edu
- Journal
- Am Fam Physician. 2006 Dec 15;74(12):2046-54.
- Abstract URL
- Click here to view abstract
70. Rasagiline (Azilect) for Parkinson's disease.
- Author
- Institution
- Journal
- Med Lett Drugs Ther. 2006 Dec 4;48(1249/1250):97-9.
